Post-vasectomy home sperm test receives FDA nod
The FDA has approved SpermCheck Vasectomy (ContraVac, Inc., Charlottesville, VA), a diagnostic product that confirms men’s post-vasectomy sterility. The device will enable men to test their post-vasectomy fertility status at home, rather than returning to the physician’s office or a laboratory for confirmation.
The FDA has approved SpermCheck Vasectomy (ContraVac, Inc., Charlottesville, VA), a diagnostic product that confirms men’s post-vasectomy sterility. The device will enable men to test their post-vasectomy fertility status at home, rather than returning to the physician’s office or a laboratory for confirmation.
Similar to a home pregnancy test for women, the test has the sensitivity and specificity required to detect low numbers of sperm, according to ContraVac. The test will be available in mid-2008. Physicians will be able to provide the product to their patients who undergo vasectomy, or men can order the product directly from the vendor.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.
